← Evidence map

ArticleJournal of clinical medicine2025

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Carlos Martínez-Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit. | Socratic